Pays: États-Unis
Langue: anglais
Source: NLM (National Library of Medicine)
TOBRAMYCIN (UNII: VZ8RRZ51VK) (TOBRAMYCIN - UNII:VZ8RRZ51VK), DEXAMETHASONE (UNII: 7S5I7G3JQL) (DEXAMETHASONE - UNII:7S5I7G3JQL)
NuCare Pharmaceuticals,Inc.
OPHTHALMIC
PRESCRIPTION DRUG
Tobramycin and dexamethasone ophthalmic suspension is indicated for steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where superficial bacterial ocular infection or a risk of bacterial ocular infection exists. Ocular steroids are indicated in inflammatory conditions of the palpebral and bulbar conjunctiva, cornea and anterior segment of the globe where the inherent risk of steroid use in certain infective conjunctivitides is accepted to obtain a diminution in edema and inflammation. They are also indicated in chronic anterior uveitis and corneal injury from chemical, radiation or thermal burns, or penetration of foreign bodies. The use of a combination drug with an anti-infective component is indicated where the risk of superficial ocular infection is high or where there is an expectation that potentially dangerous numbers of bacteria will be present in the eye. The particular anti-infective drug in this product is active against the following common bacterial eye
Tobramycin and Dexamethasone Ophthalmic Suspension, USP 0.3%/0.1% is supplied in a plastic bottle with a controlled drop tip and pink cap in the following sizes: NDC 68071-2418-2 2.5 mL Store upright at 20° to 25°C (68° to 77°F). Shake well before using. Distributed by: Bausch + Lomb, a division of Bausch Health US, LLC Bridgewater, NJ 08807 USA Manufactured by: Bausch & Lomb Incorporated Tampa, FL 33637 USA © 2020 Bausch & Lomb Incorporated or its affiliates Revised July 2020 9090705 (folded) 9090605 (flat)
Abbreviated New Drug Application
TOBRAMYCIN AND DEXAMETHASONE- TOBRAMYCIN AND DEXAMETHASONE SUSPENSION/ DROPS NUCARE PHARMACEUTICALS,INC. ---------- TOBRAMYCIN AND DEXAMETHASONE OPHTHALMIC SUSPENSION, USP 0.3%/0.1% (STERILE) RX ONLY FOR OPHTHALMIC USE ONLY DESCRIPTION Tobramycin and Dexamethasone Ophthalmic Suspension, USP 0.3%/0.1% is a sterile, multiple dose antibiotic and steroid combination for topical ophthalmic use. Tobramycin is represented by the following structural formula: Molecular formula: C H N O Molecular weight: 467.52 Chemical Name: _0_-3-Amino-3-deoxy-α-D-glucopyranosyl-(1→4)- _0_-[(2,6-diamino-2,3,6- tridexoxy-α-D- _ribo_-hexopyranosyl-(1→6)]-2-deoxy-L-streptamine Dexamethasone is represented by the following structural formula: Molecular formula: C H FO Molecular weight: 392.47 Chemical Name: 9-Fluoro-11β,17,21-trihydroxy-16α-methylpregna-1,4-diene-3,20-dione EACH ML CONTAINS: ACTIVES: Tobramycin 3 mg (0.3%) and Dexamethasone 1 mg (0.1%); INACTIVES: Edetate Disodium, Hydroxyethyl Cellulose, Purified Water, Sodium Chloride, Sodium Sulfate, and Tyloxapol. Sulfuric Acid and/or Sodium Hydroxide may be added to adjust pH (5.0 – 6.0). PRESERVATIVE ADDED: Benzalkonium Chloride 0.01%. CLINICAL PHARMACOLOGY Corticoids suppress the inflammatory response to a variety of agents and they probably delay or slow healing. Since corticoids may inhibit the body’s defense mechanism against infection, a concomitant antimicrobial drug may be used when this inhibition is considered to be clinically significant. Dexamethasone is a potent corticoid. The antibiotic component in the combination (tobramycin) is included to provide action against susceptible organisms. In vitro studies have demonstrated that tobramycin is active against susceptible strains of the following microorganisms: _Staphylococci_, including _S. aureus _and _S. epidermidis _(coagulase-positive and coagulase- 18 37 5 9 22 29 5 negative), including penicillin-resistant strains. _Streptococci_, including some of the Group A-beta-hemolytic species, some nonhemolytic speci Lire le document complet